Previous 10 | Next 10 |
Arena Pharmaceuticals, Inc. (ARNA) Q1 2019 Results Earnings Conference Call May 08, 2019, 04:30 PM ET Company Participants Kevin Lind - Chief Financial Officer Amit Munshi - President & Chief Executive Officer Preston Klassen - Chief Medical Officer . Conference Call Parti...
On today’s podcast, we sit down with Dan Ahrens, the portfolio manager of the AdvisorShares Pure Cannabis ETF ( YOLO ), the first actively managed ETF with a dedicated cannabis investment mandate domiciled in the United States. Dan is no stranger to the investing in vice stocks (tobacco...
Arena Pharmaceuticals (NASDAQ: ARNA ): Q1 GAAP EPS of $12.10 misses by $2.17 . More news on: Arena Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
SAN DIEGO , May 8, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the first quarter ended March 31, 2019 . "We are continuing to make significant progress on advancing our internally developed poten...
AAOI , AIMT , AKCA , ALB , ANGI , APLE , ARNA , ASRT , AXGN , BIO , BREW , CCMP , CECO , CNDT , COLL , CPA , CTL , CVNA , CW , CWH , CXW , DAR , DHT , DIS , DRH , DVAX , ECPG , EGAN , ELF , ENV , ET , ETSY , EVRG , EZPW , FLNT , FNV , FOSL , FOXA , FTK...
Arena Pharmaceuticals (NASDAQ: ARNA ) is scheduled to announce Q1 earnings results on Wednesday, May 8th, after market close. More news on: Arena Pharmaceuticals, Inc., Earnings news and commentary, , Healthcare stocks news, Read more ...
SAN DIEGO , May 1, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will release its first quarter 2019 financial results and provide a corporate update on Wednesday, May 8, 2019 , after the close of the U.S. financial markets. The Company will host a conference cal...
Safety First: NASCAR driver Johanna Long and her helmet (Credit: Gearheads ) Bulletproof Investing: Week 71 Performance Each week since the beginning of June 2017, I have presented at least two hedged portfolios created by Portfolio Armor to my Bulletproof Investing subscribers....
SAN DIEGO , April 3, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Amit D. Munshi , the Company's President and Chief Executive Officer, will present a corporate update at the 18th Annual Needham Healthcare Conference on Wednesday, April 10, 2019...
Biogen ( BIIB ) is a biotechnology company founded by several notable scientists, two Nobel Prize recipients and one knighted. Biogen gained prominence during the late 90's for FDA and European approval of the interferon Avonex for the treatment of relapsing forms of multiple sclerosis (MS'), ...
News, Short Squeeze, Breakout and More Instantly...
Arena Pharmaceuticals Inc. Company Name:
ARNA Stock Symbol:
NASDAQ Market:
Arena Pharmaceuticals Inc. Website:
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) traded at a new 52-week high today of $99.95. So far today approximately 748,000 shares have been exchanged, as compared to an average 30-day volume of 1.2 million shares. Arena Pharmaceuticals is a biotechnology company targeting G-protein-couple...
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) traded today at a new 52-week high of $98.57. So far today approximately 748,000 shares have been exchanged, as compared to an average 30-day volume of 1.1 million shares. Over the past year, Arena Pharmaceuticals Inc. has traded in a range of $45...